Eli Lilly & Co. (LLY) Issues FY13 Earnings Guidance
Eli Lilly & Co. (NYSE:LLY) updated its FY13 earnings guidance on Wednesday. The company provided EPS guidance of $4.10-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.13, Analyst Ratings Network.com reports. The company issued revenue guidance of $22.6-23.4 billion, compared to the consensus revenue estimate of $22.95 billion.
Several analysts have recently commented on the stock. Analysts at Jefferies Group downgraded shares of Eli Lilly & Co. from a hold rating to an underperform rating in a research note to investors on Friday, October 11th. They now have a $40.00 price target on the stock, down previously from $49.00. On a related note, analysts at Edward Jones upgraded shares of Eli Lilly & Co. from a sell rating to a hold rating in a research note to investors on Thursday, October 10th. Finally, analysts at Credit Suisse initiated coverage on shares of Eli Lilly & Co. in a research note to investors on Tuesday, October 8th. They set a neutral rating on the stock. Two analysts have rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of $55.53.
Eli Lilly & Co. (NYSE:LLY) opened at 50.15 on Wednesday. Eli Lilly & Co. has a one year low of $44.68 and a one year high of $58.40. The stock’s 50-day moving average is $52.91 and its 200-day moving average is $53.74. The company has a market cap of $54.172 billion and a price-to-earnings ratio of 11.26.
Eli Lilly & Co. (NYSE:LLY) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.07. The company had revenue of $5.77 billion for the quarter, compared to the consensus estimate of $5.76 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. Analysts expect that Eli Lilly & Co. will post $4.14 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, December 10th. Shareholders of record on Friday, November 15th will be given a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 3.91%. The ex-dividend date of this dividend is Wednesday, November 13th.
Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.